SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Micawber who wrote (2666)9/7/1999 9:50:00 PM
From: Scott H. Davis  Respond to of 4676
 
Obviously very off, but do remember to factor in the terrible small cap & especially biotech market that started 2nd half 96 until this year. ISIP, VICL & LGND are all well off where they were in 1st half 96. I thought I was smart and waited till after the 97 tax loss season to jump into ISIP & VICL. All this did was allow me to hold dead money rather than suffer a paper loss. Oh well. With biotech as a whole I'm actually up - better than a CD but way off a brain dead S&P 500 index fund return during that time period. Computer storage and networking are another issue
(hence the reason 4 diversification) Scott



To: Micawber who wrote (2666)9/8/1999 4:05:00 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 4676
 
Ibis Therapeutics, a Division of Isis Pharmaceuticals, Creates New Method to Discover RNA-Binding Drugs
biz.yahoo.com

I suspect this may be of interest to potential partners also. let the good news roll. Scott